Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/23/2012CN101209321B Medicament for treating burn and scald
05/23/2012CN101203507B 2-substituted benzimidazoles
05/23/2012CN101199848B Drug compound for Ca channel retarder/diuretic/ folate coupling and function
05/23/2012CN101199505B Verapamil liposome and preparing method thereof
05/23/2012CN101184738B Purified form of tanaproget
05/23/2012CN101177438B N-acetylglucosamine derivatives and use thereof
05/23/2012CN101176721B Hexamethylmelamine liposome and preparation method thereof
05/23/2012CN101160121B Compositions for treating cancer
05/23/2012CN101155800B Pyrazolylaminopyridine derivatives useful as kinase inhibitors
05/23/2012CN101142208B 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication
05/23/2012CN101138566B Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds
05/23/2012CN101137639B Flavonoid compounds and uses thereof
05/23/2012CN101119978B HSP90-inhibiting triazole derivatives
05/23/2012CN101103013B 1-thio-D-glucitol derivatives
05/23/2012CN101065396B Process for the preparation of drospirenone
05/23/2012CN101061098B Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
05/23/2012CN101045046B Use of Brazil hemoatoxy type compound for preparing antineoplastic
05/23/2012CN101023077B Method for manufacturing enantiomeric imidazole compounds
05/23/2012CN101014348B Ethanol extraction of phytosterols from corn fiber
05/23/2012CN101010071B Method for producing a solid dosage form, which is safeguarded against abuse, while using a planetary gear extruder
05/22/2012US8183414 N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as subtype selective modulators of ALPHA2B or ALPHA2B and ALPHA2C adrenoceptors
05/22/2012US8183405 Obovatol derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for the prevention and treatment of cancer containing the same as an active ingredient
05/22/2012US8183401 Aromatase inhibitor; deprotonation
05/22/2012US8183398 5-hydroxy-2-methyl-4H-pyran-4-one esters as novel tyrosinase inhibitors
05/22/2012US8183395 Compositions and methods for treating cancer
05/22/2012US8183391 Process for preparing dorzolamide
05/22/2012US8183388 Androgen receptor modulator and uses thereof
05/22/2012US8183384 Triazole compounds that modulate HSP90 activity
05/22/2012US8183383 Protein tyrosine phosphatase 1B inhibitor, preparation methods and uses thereof
05/22/2012US8183379 Antitumor agents
05/22/2012US8183374 Piperidine and piperazine derivatives
05/22/2012US8183369 4- [3- (4-cyclopropanecarbonyl-piperazine-I-carbonyl) -4 -fluoro-benzyl] -2H-phthalaz in-1-one
05/22/2012US8183366 Chemokine receptor antagonists
05/22/2012US8183364 Substituted porphyrins
05/22/2012US8183363 Antisense oligonucleotide modulation of STAT3 expression
05/22/2012US8183362 Method and medicament for inhibiting the expression of a given gene
05/22/2012US8183361 Oligonucleotide-containing pharmacological compositions and their use
05/22/2012US8183352 Attenuated vif DNA immunization cassettes for genetic vaccines
05/22/2012US8183351 Avermectin derivatives
05/22/2012US8183350 Compositions and methods for promoting neuronal outgrowth
05/22/2012US8183297 Medium and device for proliferation of stem cells and treatment of cancer-related stem cell with resveratrol
05/22/2012US8183295 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
05/22/2012US8183294 Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation
05/22/2012US8183293 Phenyl acetic acid derivatives
05/22/2012US8183292 Chiral cyclic β-amino acids and their derivatives, pharmaceutical compositions containing them and the use of such compounds
05/22/2012US8183291 Clear ophthalmic solution comprising latanoprost as active ingredient
05/22/2012US8183290 Pharmaceutically acceptable propylene glycol solvate of naproxen
05/22/2012US8183288 Amino acid compounds
05/22/2012US8183287 Pharmaceutical formulations and compositions of a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 and methods of using the same for treating inflammatory disorders
05/22/2012US8183286 EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
05/22/2012US8183285 Therapeutic agent for irritable bowel syndrome and methods thereof
05/22/2012US8183284 Compositions for reducing the incidence of drug induced arrhythmia
05/22/2012US8183283 Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same
05/22/2012US8183282 Therapeutic uses of urolithins
05/22/2012US8183281 CXC-chemokine receptor ligands
05/22/2012US8183280 FAP inhibitors
05/22/2012US8183279 1,3-dihydroisoindole derivatives
05/22/2012US8183278 Compounds
05/22/2012US8183277 Inhibitors of HCV replication of formula (I)** Image-1whereinW is a heterocycle of formula** Image-2and the remaining variables are as defined in the specification.
05/22/2012US8183276 Therapeutic agents
05/22/2012US8183275 Substituted imidazoles as bombesin receptor subtype-3 modulators
05/22/2012US8183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds
05/22/2012US8183273 Bicyclic compound, production and use thereof
05/22/2012US8183272 Indanyl compounds
05/22/2012US8183271 Tetrazole derivatives and their use for the treatment of cardiovascular diseases
05/22/2012US8183269 Process for the preparation of rufinamide
05/22/2012US8183267 Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
05/22/2012US8183266 Methods
05/22/2012US8183265 2-adamantyl-butyramide derivatives as selective 11β-HSD1 inhibitors
05/22/2012US8183264 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
05/22/2012US8183263 Heteroaryl substituted thiazoles
05/22/2012US8183262 Pyridine derivatives as mGluR2 antagonists
05/22/2012US8183260 small molecule, low toxicity, high efficiency, high economic value; 5-(2,6-dioxopiperidin-3-yl)-5H-thieno(3,4-c)pyrrole-4,6-dione:
05/22/2012US8183259 Heterocyclic compounds and their uses
05/22/2012US8183258 Heterocyclic compounds and their uses
05/22/2012US8183257 Muscarinic acetylcholine receptor antagonists
05/22/2012US8183256 Remedy or preventive for integration dysfunction syndrome
05/22/2012US8183255 N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitors
05/22/2012US8183254 Inhibitors of JNK
05/22/2012US8183253 Condensing (3-trifluoromethylsulfonyl) benzoyl chloride and 4-methyl-2-nitro-aniline; reducing nitro group with stannous chloride; condensing amino group with cyanamide; cyclocondensing guanidine group with 3-dimethylamino-1-pyridin-3-yl-propenone; antiproliferative agents; chronic myeloid leukemia
05/22/2012US8183252 Heterocyclic aspartyl protease inhibitors
05/22/2012US8183251 1-[(4S)-4-cyclopropyl-2,5-dioxoimidazolidin-4-yl]-N-methyl-N-{[4-(pyrimidin-5-yloxy)phenyl]methyl}methanesulfonamide; matrix metalloproteinase inhibitors; obstructive airways disease is asthma or chronic obstructive pulmonary disease
05/22/2012US8183250 Potent PARP inhibitors
05/22/2012US8183249 Inhibitors of AKT/PKB with anti-tumor activity
05/22/2012US8183248 Substituted pyrrolo[2,3-d]pyrimidines and compositions as protein kinase inhibitors
05/22/2012US8183247 Boron compounds useful in BNCT
05/22/2012US8183246 Acyclically substituted furopyrimidine derivatives and use thereof
05/22/2012US8183245 Pyrazine substituted pyrrolopyridines as inhibitors of JAK and PDK1
05/22/2012US8183244 Glycine transporter-1 inhibitors
05/22/2012US8183242 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
05/22/2012US8183241 2-oxo-1-pyrrolidine derivatives
05/22/2012US8183240 Heteroaryls and uses thereof
05/22/2012US8183239 Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor
05/22/2012US8183238 Bicyclic and tricyclic compounds as KAT II inhibitors
05/22/2012US8183237 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
05/22/2012US8183236 Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics
05/22/2012US8183235 Dihydronaphthalene compound and use thereof
05/22/2012US8183233 Stable pharmaceutical formulations
05/22/2012US8183232 Therapeutic agent for hemorrhoidal disease
05/22/2012US8183231 Substituted propane phosphinic acid derivatives
1 ... 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 ... 7860